66 related articles for article (PubMed ID: 15251971)
1. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung.
Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au JS; Law CK
Ann N Y Acad Sci; 2004 Jun; 1022():263-70. PubMed ID: 15251971
[TBL] [Abstract][Full Text] [Related]
2. Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study.
Zhou Y; Huang J; Lan J; Hu H; Yuan Z; Dong L; Deng H; Yue LA; Xiao Y; Yang X
J Cancer Res Ther; 2023 Aug; 19(4):1011-1018. PubMed ID: 37675730
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review.
Hu Y; Ren S; Liu Y; Han W; Liu W
Onco Targets Ther; 2020; 13():3921-3929. PubMed ID: 32494151
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Lymphoepithelioma-like Carcinoma.
Sathirareuangchai S; Hirata K
Arch Pathol Lab Med; 2019 Aug; 143(8):1027-1030. PubMed ID: 30672338
[TBL] [Abstract][Full Text] [Related]
5. Primary pulmonary lymphoepithelioma-like carcinoma with positive expression of Epstein-Barr virus and PD-L1: A case report.
Sasaki A; Kato T; Ujiie H; Cho Y; Sato M; Kaji M
Int J Surg Case Rep; 2021 Feb; 79():431-435. PubMed ID: 33529823
[TBL] [Abstract][Full Text] [Related]
6. Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma.
Li QW; Qiu B; Hu WM; Guo SP; Wu YJ; Zhu YJ; Hu N; Ai XL; Chen NB; Guo JY; Hu YH; Liu MZ; Zeng MS; Liu H
Front Oncol; 2020; 10():1487. PubMed ID: 32974179
[No Abstract] [Full Text] [Related]
7. Distinct Molecular Landscape of Epstein-Barr Virus Associated Pulmonary Lymphoepithelioma-Like Carcinoma Revealed by Genomic Sequencing.
Chau SL; Tong JH; Chow C; Kwan JS; Lung RW; Chung LY; Tin EK; Wong SS; Cheung AH; Lau RW; Ng CS; Mok TS; Lo KW; To KF
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726920
[TBL] [Abstract][Full Text] [Related]
8. Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden.
Wu Q; Wang W; Zhou P; Fu Y; Zhang Y; Shao YW; Jiang L
Pathol Res Pract; 2020 Aug; 216(8):153043. PubMed ID: 32703503
[TBL] [Abstract][Full Text] [Related]
9. Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably To Nivolumab: A Case Report.
Qiu ZX; Zhou P; Wang K
Onco Targets Ther; 2019; 12():8595-8600. PubMed ID: 31802895
[TBL] [Abstract][Full Text] [Related]
10. Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma.
Chen B; Chen X; Zhou P; Yang L; Ren J; Yang X; Li W
Respir Res; 2019 Nov; 20(1):262. PubMed ID: 31752892
[TBL] [Abstract][Full Text] [Related]
11. First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Lin Z; Fu S; Zhou Y; Zhang X; Chen C; He LN; Li H; Wang Y; Chen T; Zhang L; Hong S
Lung Cancer; 2019 Nov; 137():100-107. PubMed ID: 31568886
[TBL] [Abstract][Full Text] [Related]
12. EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade.
Narayanan A; Knollmann FD; Walby JAS; Lim S; Gandara DR; Riess JW
Clin Lung Cancer; 2019 May; 20(3):e238-e241. PubMed ID: 30679078
[No Abstract] [Full Text] [Related]
13. Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT.
Aktas GE; Can N; Demir SS; Sarıkaya A
Nucl Med Mol Imaging; 2017 Mar; 51(1):88-92. PubMed ID: 28250863
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival.
Fang W; Hong S; Chen N; He X; Zhan J; Qin T; Zhou T; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Tang Y; Huang Y; Zhao H; Zhang L
Oncotarget; 2015 Oct; 6(32):33019-32. PubMed ID: 26361045
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy.
Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
Lung Cancer; 2015 Jun; 88(3):254-9. PubMed ID: 25862146
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients.
Xie M; Wu X; Wang F; Zhang J; Ben X; Zhang J; Li X
J Thorac Oncol; 2018 Feb; 13(2):218-227. PubMed ID: 29191777
[TBL] [Abstract][Full Text] [Related]
17. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
Liang Y; Wang L; Zhu Y; Lin Y; Liu H; Rao H; Xu G; Rong T
Cancer; 2012 Oct; 118(19):4748-58. PubMed ID: 22359203
[TBL] [Abstract][Full Text] [Related]
18. Lymphoepithelioma-like carcinoma of the lung.
Ho JC; Wong MP; Lam WK
Respirology; 2006 Sep; 11(5):539-45. PubMed ID: 16916325
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung.
Bégin LR; Eskandari J; Joncas J; Panasci L
J Surg Oncol; 1987 Dec; 36(4):280-3. PubMed ID: 2826922
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study.
Zou QH; Liu H; Huang CW; Kang LP; Qiu B; Mai JL; Lin YB; Liang Y
Transl Lung Cancer Res; 2023 Jan; 12(1):96-108. PubMed ID: 36762055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
